Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
Unsplash
Sep 28, 2021

Presenting Health Incubator Helsinki batch 2 companies:

Phonolyser tracks down Congenital Heart Disease in newborns

Helsinki startup Phonolyser is taking on Congenital Heart Disease (CHD) which is a structural heart defect present already at birth. As it is also the most common birth defect in the world, all medical solutions are of critical importance in order to safeguard the infants’ health and wellbeing. Phonolyser is one of the promising health startups selected for the Health Incubator Helsinki program that started in the spring of 2021.

Bahman Doaeian, Chief Business Officer at Phonolyser, points out that every year, around 1.35 million babies are born with CHD worldwide.

“CHD is the most common cause of birth defect-related infant death – and despite its vast prevalence, public awareness about CHD and also the funding to address this issue seem really underwhelming at this point,” Bahman says. It is estimated that approximately 200-300 babies each year are discharged from the US hospitals with an undiagnosed CHD.

Phonolyser wants to change all this with its device by the same name: Phonolyser™ is a groundbreaking smart heart analyzer for pediatricians and healthcare staff to differentiate innocent murmurs from pathologic ones. It is packed with technologies such as AI, doppler, ECG, and sound to detect and diagnose CHD with a remarkable degree of confidence (Sensitivity: 98%).

Bahman Doaeian Phonolyser
Roope Permanto

Phonolyser™ helps healthcare professionals identify and diagnose CHD more effectively and faster than ever before.

Bahman Doaeian, Chief Business Officer, Phonolyser

Accurate screening and diagnosis tool – for all healthcare personnel

Phonolyser™ shows in what phase of the cardiac cycle the murmur is occurring (systolic or diastolic), the intensity of the murmur, its location, and in what direction it is radiated.

 “All of this information can help and lead the physician to the most accurate category of diagnosis,” Bahman says.

According to Bahman, Phonolyser™ is a revolutionary new device since it is accurate, real-time, and affordable, helping healthcare professionals identify and diagnose congenital heart disease more effectively and faster than ever before.

“What’s more, every doctor and member of the healthcare staff can use it: it’s not meant only for specialists and cardiologists,” adds Bahman.

Phonolyser team members standing together
Roope Permanto

Phonolyser team from left: Javad Maleki, Sanaz Naderi, Jalmari Talola, Bahman Doaeian, Markus Tuukkanen and Farnaz Farahdel

Saving healthcare costs

Avoiding loss of life and helping babies grow up healthy is, of course, paramount here. Nevertheless, there are other concerns, too: for example, although most infants diagnosed with CHD are healthy, every year more than 10 million babies are referred to pediatric cardiologists.

“The problem of unnecessary referrals costs huge amounts of money and time and we’re here to save the healthcare industry billions,” says Bahman.

Examining a patient in three minutes

Founded in 2017, the startup hit the ground running and put together the first version of its device in August of the same year.

“It was doppler based – and made out of a biscuit box,” reveals Bahman.

Evolution continued: Launched in April 2019, version 2.0 combined Doppler with AI and ECG; newest version, 3.0., which came out in May 2020, has added sound to the mix.

“The present version is two times faster than what we started with. Now it takes less than three minutes to examine a patient,” says Bahman.  

Examining a baby doll with Phonolyser's smart heart analyzer
Roope Permanto

Finland is the place to be in healthcare

Presently, Phonolyser team is “very excited” to be one of the 13 outstanding startups of the Health Incubator Helsinki 2021 program.

“We plan to use the resources and mentorship that the program brings us to help more people live healthier and longer lives,” Bahman says.

“Finland is simply the place to be, if you want to build a healthcare business that centers on children,” he concludes.

Check out all the companies in the Health Incubator Helsinki program

Text: Sami J. Anteroinen

Phonolyser logo

Fast Facts

Name: Phonolyser Oy

Product: Phonolyser™, accurate screening tool for pediatricians and healthcare staff to diagnose children

Founded: 2017

Team size: 8

Target customer/market: Healthcare professionals working with infants, newborns and children

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

More case stories

Health Capital Helsinki

Lumoral device and batteryKoite Health

Brushing your teeth is not enough – Finnish innovation reduces gingivitis efficiently

Nov 23, 2022
https://healthcapitalhelsinki.fi/wp-content/uploads/2022/11/Lumoral-laite-ja-akku-copy-res72.jpg 883 1335 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-11-23 14:04:292022-11-24 10:15:13Brushing your teeth is not enough – Finnish innovation reduces gingivitis efficiently
Design model of a wrist device to curb alcohol cravingsJuliana Harkki

Skin-stroking device to help curb alcohol cravings developed in Finland

https://healthcapitalhelsinki.fi/wp-content/uploads/2022/11/hentoTouch_ranne_v2_w1000.jpg 736 1000 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-11-14 16:13:032022-11-14 16:13:25Skin-stroking device to help curb alcohol cravings developed in Finland
Mobile phone and Olo wellness appNature Solutions

Finnish startup Olo delivers the perfect sonic recharge

Sep 14, 2022
https://healthcapitalhelsinki.fi/wp-content/uploads/2022/09/Olo-app-1500x1000-1.jpg 1000 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-09-14 08:00:462022-09-15 13:30:51Finnish startup Olo delivers the perfect sonic recharge
News

Health Capital Helsinki

Helsinki Partners
Kasarmikatu 36
00130 HELSINKI
FINLAND

Privacy notice

Sign up to our newsletter

Subscribe

Follow us

  • twitter
  • linkedin
Health Capital Helsinki
Scroll to top

We use cookies to give you the best experience on our website.

Find out more and set your preferences settings.

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

We also use Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice